IMU 7.14% 6.0¢ imugene limited

From the study description:Primary Outcome Measures:1.Incidence...

  1. 73 Posts.
    lightbulb Created with Sketch. 34
    From the study description:

    Primary Outcome Measures:1.

    Incidence of adverse events[ Time Frame: Up to 30 days ]Toxicity will be graded according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 5.0. Observed toxicities/adverse events will be summarized in terms of type (organ affected or laboratory determination), severity, time of onset, duration, probable association with the study treatment and reversibility or outcome.

    That's box 1 ticked!! Well done.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.004(7.14%)
Mkt cap ! $440.9M
Open High Low Value Volume
5.7¢ 6.3¢ 5.6¢ $1.312M 21.97M

Buyers (Bids)

No. Vol. Price($)
7 299223 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 450000 3
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.